Peritoneal Dialysis Market is segmented By Type Of Product (Implantation systems, Peritoneal solutions, Peritoneal dialyzers, Peritoneal dialysis catheters, and others), By Type Of Treatment (Automated peritoneal dialysis, continuous ambulatory peritoneal dialysis), By end-user (Home Health Care, Hospital and others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Peritoneal Dialysis Market size was valued at USD 4,153.90 million in 2021 and is estimated to reach at a compound annual growth rate (CAGR) of 6.00% over the forecast period 2022 to 2029. Peritoneal dialysis is a treatment for kidney failure that uses the lining of the patient’s abdomen, or belly, to filter the blood inside his/her body. As per the research study, the global market is segmented into type of product, type of treatment, end user, and region. Based on region the market is divided into five major regions such as North America, Europe, Asia Pacific, South America, the Middle East and Africa, and the Rest of the globe.
South America has a moderate growth rate in the region owing to an increase in awareness about advanced dialysis devices among healthcare professionals & patients, developing healthcare infrastructure, and a higher prevalence of ESRD. According to the Brazilian Chronic Dialysis Survey 2016 published by the Brazilian Society of Nephrology (SBN), on July 1, 2016, 92.1% of the patients were on chronic renal replacement therapy, and 7.9% were on peritoneal dialysis, the majority of whom on automated peritoneal dialysis (APD).
Peritoneal dialysis was the mode of treatment for 7.7% of the patients served by the Brazilian public health care system (SUS) versus 9.0% of the individuals covered by private health insurance, driving the market demand for end-products. Although there is universal peritoneal dialysis coverage in Brazil, access to care is not uniform. Some patients with renal failure, particularly the oldest ones, those of lower social class, or those living far from health care centers with dialysis facilities (particularly in the north and northeast regions of the country), may not receive timely treatment. There is still considerable room for improvement regarding the integration of primary care facilities with more advanced health care centers.
Market Dynamics
The rising prevalence of end-stage renal disease and surge in demand for home dialysis treatment is anticipated to drive the peritoneal dialysis (PD) equipment segment.
Peritoneal dialysis is an effective form of dialysis and has been proven to be as good as hemodialysis. Peritoneal dialysis is not for everyone. People must receive training and be able to correctly perform each of the steps of the treatment. A trained helper may also be used. It is done more continuously than hemodialysis, resulting in less accumulation of potassium, sodium, and fluid. This allows patients to have a more flexible diet than could have on hemodialysis. Longer lasting residual kidney function.
Peritoneal dialysis can be done at home, at work, or while traveling. Hemodialysis is typically done in a health care setting, such as a dialysis center or hospital, though it can sometimes be done at home. So peritoneal dialysis is more convincible than hemodialysis. Although both types of dialysis can effectively filter blood people who use peritoneal dialysis might retain kidney function slightly longer than people who use hemodialysis.
Patients getting hemodialysis usually need treatments three times a week. Each treatment takes around four hours. While this may be inconvenient, many patients with low kidney function benefit from hemodialysis. Peritoneal dialysis is a good option for patients that meet certain health requirements and want fewer restrictions than they would have with hemodialysis.
Peritoneal Dialysis Market Scope
Metrics |
Details |
Market CAGR |
6.00% |
Segments Covered |
By Type Of Product, By Type Of Treatment, By End User, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
To know more insights into the Market, Get Our Sample Brochure
Market Segmentation
Based on Product Type, the market is segmented into Peritoneal Dialysis Machines, Peritoneal Dialysis Concentrates/Dialysates, Peritoneal Dialysis Catheters, Peritoneal Solution, Peritoneal Dialysis Transfer Sets, and Other Accessories
Peritoneal Dialysis Machines
Peritoneal dialysis machines are increasingly being used by patients due to the flexibility and freedom of peritoneal dialysis. The peritoneal dialysis machine cleans the blood using the lining of the abdomen. The catheter is placed into part of the abdomen and the catheter helps in filtering blood through the peritoneum, a lining of the abdomen, by absorbing toxins and removing them together with excess water. This dialysis is less complex than hemodialysis treatment and it can be done anywhere -at home, at work, or on travel. According to the German dialysis products and services provider, Fresenius Medical Care’s 2019 report, globally, around 9% of chronic kidney failure patients are under peritoneal dialysis treatment and about 11% of all dialysis patients preferred peritoneal dialysis treatment.
The introduction of technologically advanced and user-friendly dialysis machines is expected to drive the segment growth. Hence, the companies in the peritoneal dialysis machines market are focusing on technological developments to improve the accessibility of dialysis treatment to patients.
For instance, in January 2019, Fresenius Medical Care launched a 4008A dialysis machine tailored to needs in emerging markets. This machine is aimed to improve accessibility to life-sustaining dialysis treatment for patients in emerging markets who are living with end-stage renal disease (ESRD). Also in October 2019, Fresenius Medical Care wins Food and Drug Administration (FDA) breakthrough nod for clot-preventing dialysis devices. This device aims to prevent blood clotting without the use of blood thinner medication. Such technological advancements are expected to drive the peritoneal dialysis machines market from USD 906.1 million in 2020 to USD 1,387.8 million in 2028, growing with a CAGR of 5.7% during the forecast period.
Competitive Landscape
The peritoneal dialysis market is highly competitive. Some of the major players in the market include Baxter International, Fresenius Kabi AG, Medtronic, Utah Medical Products, Glomeria Therapeutics, Poly Medicure Ltd., Cook Medical Inc., CardioMed Supplies, Inc., Medical Components, Inc, and Renax Biomedical Tech. Co., Ltd. In the peritoneal dialysis market, companies are focusing on mergers and acquisitions and also on strategic moves to acquire greater market share.
The peritoneal dialysis market is competitive with the presence of a few big firms and many small firms worldwide that have similar product offerings. Efficient distribution networks, product differentiation, and supply competency play a major role in determining the market position of such players. The majority of these players are focusing on expanding distribution networks as well as expanding presence in the Asia Pacific, Latin America, and the Middle East regions due to increasing awareness and increasing disposable income. New Product Launches, partnerships, and acquisitions are the major strategies adopted by the leading companies in the industry. The companies are heavily investing in the market to develop new products and are collaborating and acquiring other companies which helps in increasing their market share.